List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Blood Transfusion Diagnostics Revenue in Blood Transfusion Diagnostics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Blood Transfusion Diagnostics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Blood Transfusion Diagnostics Market Size for the Year 2017-2028
1.2.2 Global Blood Transfusion Diagnostics Market Size for the Year 2017-2028
1.3 Blood Transfusion Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Blood Transfusion Diagnostics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Blood Transfusion Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Blood Transfusion Diagnostics Market Dynamics
1.4.1 Blood Transfusion Diagnostics Industry Trends
1.4.2 Blood Transfusion Diagnostics Market Drivers
1.4.3 Blood Transfusion Diagnostics Market Challenges
1.4.4 Blood Transfusion Diagnostics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Blood Transfusion Diagnostics by Type
2.1 Blood Transfusion Diagnostics Market Segment by Type
2.1.1 ELISA
2.1.2 NAT
2.1.3 Western Blot Assays
2.1.4 Fluorescence Assay
2.1.5 Other Technology
2.2 Global Blood Transfusion Diagnostics Market Size by Type (2017, 2022 & 2028)
2.3 Global Blood Transfusion Diagnostics Market Size by Type (2017-2028)
2.4 United States Blood Transfusion Diagnostics Market Size by Type (2017, 2022 & 2028)
2.5 United States Blood Transfusion Diagnostics Market Size by Type (2017-2028)
3 Blood Transfusion Diagnostics by Application
3.1 Blood Transfusion Diagnostics Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Blood Banks
3.1.4 Laboratories
3.1.5 Other
3.2 Global Blood Transfusion Diagnostics Market Size by Application (2017, 2022 & 2028)
3.3 Global Blood Transfusion Diagnostics Market Size by Application (2017-2028)
3.4 United States Blood Transfusion Diagnostics Market Size by Application (2017, 2022 & 2028)
3.5 United States Blood Transfusion Diagnostics Market Size by Application (2017-2028)
4 Global Blood Transfusion Diagnostics Competitor Landscape by Company
4.1 Global Blood Transfusion Diagnostics Market Size by Company
4.1.1 Top Global Blood Transfusion Diagnostics Companies Ranked by Revenue (2021)
4.1.2 Global Blood Transfusion Diagnostics Revenue by Player (2017-2022)
4.2 Global Blood Transfusion Diagnostics Concentration Ratio (CR)
4.2.1 Blood Transfusion Diagnostics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Blood Transfusion Diagnostics in 2021
4.2.3 Global Blood Transfusion Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Blood Transfusion Diagnostics Headquarters, Revenue in Blood Transfusion Diagnostics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Blood Transfusion Diagnostics Headquarters and Area Served
4.3.2 Global Blood Transfusion Diagnostics Companies Revenue in Blood Transfusion Diagnostics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Blood Transfusion Diagnostics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Blood Transfusion Diagnostics Market Size by Company
4.5.1 Top Blood Transfusion Diagnostics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Blood Transfusion Diagnostics Revenue by Players (2020, 2021 & 2022)
5 Global Blood Transfusion Diagnostics Market Size by Region
5.1 Global Blood Transfusion Diagnostics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Blood Transfusion Diagnostics Market Size by Region (2017-2028)
5.2.1 Global Blood Transfusion Diagnostics Market Size by Region: 2017-2022
5.2.2 Global Blood Transfusion Diagnostics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Blood Transfusion Diagnostics Market Size YoY Growth 2017-2028
6.1.2 North America Blood Transfusion Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Blood Transfusion Diagnostics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Blood Transfusion Diagnostics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Blood Transfusion Diagnostics Market Size YoY Growth 2017-2028
6.3.2 Europe Blood Transfusion Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Blood Transfusion Diagnostics Market Size YoY Growth 2017-2028
6.4.2 Latin America Blood Transfusion Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Blood Transfusion Diagnostics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Blood Transfusion Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Grifols
7.1.1 Grifols Company Details
7.1.2 Grifols Business Overview
7.1.3 Grifols Blood Transfusion Diagnostics Introduction
7.1.4 Grifols Revenue in Blood Transfusion Diagnostics Business (2017-2022)
7.1.5 Grifols Recent Development
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Company Details
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific Blood Transfusion Diagnostics Introduction
7.2.4 Thermo Fisher Scientific Revenue in Blood Transfusion Diagnostics Business (2017-2022)
7.2.5 Thermo Fisher Scientific Recent Development
7.3 Roche
7.3.1 Roche Company Details
7.3.2 Roche Business Overview
7.3.3 Roche Blood Transfusion Diagnostics Introduction
7.3.4 Roche Revenue in Blood Transfusion Diagnostics Business (2017-2022)
7.3.5 Roche Recent Development
7.4 bioM?rieux
7.4.1 bioM?rieux Company Details
7.4.2 bioM?rieux Business Overview
7.4.3 bioM?rieux Blood Transfusion Diagnostics Introduction
7.4.4 bioM?rieux Revenue in Blood Transfusion Diagnostics Business (2017-2022)
7.4.5 bioM?rieux Recent Development
7.5 Bio-Rad
7.5.1 Bio-Rad Company Details
7.5.2 Bio-Rad Business Overview
7.5.3 Bio-Rad Blood Transfusion Diagnostics Introduction
7.5.4 Bio-Rad Revenue in Blood Transfusion Diagnostics Business (2017-2022)
7.5.5 Bio-Rad Recent Development
7.6 Ortho Clinical Diagnostics
7.6.1 Ortho Clinical Diagnostics Company Details
7.6.2 Ortho Clinical Diagnostics Business Overview
7.6.3 Ortho Clinical Diagnostics Blood Transfusion Diagnostics Introduction
7.6.4 Ortho Clinical Diagnostics Revenue in Blood Transfusion Diagnostics Business (2017-2022)
7.6.5 Ortho Clinical Diagnostics Recent Development
7.7 Becton Dickinson
7.7.1 Becton Dickinson Company Details
7.7.2 Becton Dickinson Business Overview
7.7.3 Becton Dickinson Blood Transfusion Diagnostics Introduction
7.7.4 Becton Dickinson Revenue in Blood Transfusion Diagnostics Business (2017-2022)
7.7.5 Becton Dickinson Recent Development
7.8 Fujirebio
7.8.1 Fujirebio Company Details
7.8.2 Fujirebio Business Overview
7.8.3 Fujirebio Blood Transfusion Diagnostics Introduction
7.8.4 Fujirebio Revenue in Blood Transfusion Diagnostics Business (2017-2022)
7.8.5 Fujirebio Recent Development
7.9 DiaSorin(American Standard Companies)
7.9.1 DiaSorin(American Standard Companies) Company Details
7.9.2 DiaSorin(American Standard Companies) Business Overview
7.9.3 DiaSorin(American Standard Companies) Blood Transfusion Diagnostics Introduction
7.9.4 DiaSorin(American Standard Companies) Revenue in Blood Transfusion Diagnostics Business (2017-2022)
7.9.5 DiaSorin(American Standard Companies) Recent Development
7.10 Beckman Coulter
7.10.1 Beckman Coulter Company Details
7.10.2 Beckman Coulter Business Overview
7.10.3 Beckman Coulter Blood Transfusion Diagnostics Introduction
7.10.4 Beckman Coulter Revenue in Blood Transfusion Diagnostics Business (2017-2022)
7.10.5 Beckman Coulter Recent Development
7.11 Diagast
7.11.1 Diagast Company Details
7.11.2 Diagast Business Overview
7.11.3 Diagast Blood Transfusion Diagnostics Introduction
7.11.4 Diagast Revenue in Blood Transfusion Diagnostics Business (2017-2022)
7.11.5 Diagast Recent Development
7.12 Abbott
7.12.1 Abbott Company Details
7.12.2 Abbott Business Overview
7.12.3 Abbott Blood Transfusion Diagnostics Introduction
7.12.4 Abbott Revenue in Blood Transfusion Diagnostics Business (2017-2022)
7.12.5 Abbott Recent Development
7.13 BAG Health Care
7.13.1 BAG Health Care Company Details
7.13.2 BAG Health Care Business Overview
7.13.3 BAG Health Care Blood Transfusion Diagnostics Introduction
7.13.4 BAG Health Care Revenue in Blood Transfusion Diagnostics Business (2017-2022)
7.13.5 BAG Health Care Recent Development
7.14 Quidel
7.14.1 Quidel Company Details
7.14.2 Quidel Business Overview
7.14.3 Quidel Blood Transfusion Diagnostics Introduction
7.14.4 Quidel Revenue in Blood Transfusion Diagnostics Business (2017-2022)
7.14.5 Quidel Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
